-
Symbol
-
ALGS on Nasdaq
-
Investment type
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
210K shares
-
Security Ownership
-
3.9%
Adage Capital Management, L.P. ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)
2025-08-12 - Adage Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 210K shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).
This represents 3.9% percent ownership of the company.
In their previous filing dated 2025-02-12, Adage Capital Management, L.P. had reported owning 325K shares, indicating a decrease of -35.4% percent.